Ohara H, Miyabe Y, Deyashiki Y, Matsuura K, Hara A
Biochemistry Laboratory, Gifu Pharmaceutical University, Japan.
Biochem Pharmacol. 1995 Jul 17;50(2):221-7. doi: 10.1016/0006-2952(95)00124-i.
In this study, we compared the enzymatic reduction of 10 drugs with a ketone group by homogeneous carbonyl reductase, aldehyde reductase and three dihydrodiol dehydrogenases of human liver cytosol. At least one and in some cases all of the three dihydrodiol dehydrogenases reduced each of the ten drugs. Among these naloxone, naltrexone, befunolol, ethacrynic acid and ketoprofen were substrates specific for the dehydrogenases. The other drugs--haloperidol, metyrapone, loxoprofen, daunorubicin and acetohexamide--were highly reduced by carbonyl reductase and/or aldehyde reductase. The dihydrodiol dehydrogenases also showed lower Km values for haloperidol and loxoprofen than did carbonyl reductase. The results indicate that the three dihydrodiol dehydrogenases, as well as the two reductases, are implicated in the reduction of ketone-containing drugs in human liver cytosol.
在本研究中,我们比较了人肝细胞溶胶中的均相羰基还原酶、醛还原酶和三种二氢二醇脱氢酶对10种含酮基药物的酶促还原作用。三种二氢二醇脱氢酶中至少有一种,在某些情况下是全部三种,都能还原这10种药物中的每一种。其中,纳洛酮、纳曲酮、倍他洛尔、依他尼酸和酮洛芬是这些脱氢酶的底物特异性药物。其他药物——氟哌啶醇、美替拉酮、洛索洛芬、柔红霉素和醋磺己脲——则被羰基还原酶和/或醛还原酶高度还原。二氢二醇脱氢酶对氟哌啶醇和洛索洛芬的Km值也低于羰基还原酶。结果表明,三种二氢二醇脱氢酶以及两种还原酶都参与了人肝细胞溶胶中含酮药物的还原过程。